Although officials across several states insisted there is no shortage of anti-malaria drug hydroxychloroquine. But many Noida residents, who have arthritis and take hydroxychloroquine to treat it, say local chemists have run out of its stocks.
India has said it will allow limited exports of the anti-malaria hydroxychloroquine, officials across several states insisted there is no shortage of the drug. Hydroxychloroquine has emerged as the most sought-after medicine after preliminary trials in China suggested it boosted recovery and lowered the severity of the coronavirus disease.
The limited exports were allowed after US president Donald Trump requested the supply of the drug from India in a phone call with Prime Minister Narendra Modi. Trump also warned of retaliation if India did not take up his request.
Although officials across several states insisted there is no shortage of anti-malaria drug hydroxychloroquine. But many retail medical outlets said their stocks have exhausted after people started buying in panic. Worried, the health department has asked medical shops to supply the tablets only to the people who come with prescriptions. On hearing this from many people Today's Economics correspondent himself went along to many chemist, where all refused saying it is out of stock and we ourself are waiting for the pills.
Our correspondent also visited various chemist in NCR region and could find chemists have run out of its stocks for 15 days. There were also reports of a shortage of the medicine at chemist shops from Uttarkhand, Uttar Pradesh, West Bengal and Punjab.
No comments:
Post a Comment